Phosphodiesterase-4 Inhibitor YM976 Attenuates Pulmonary Mucus Hypersecretion of Rats

王洵,李继琼,陈磊,王海霞,孙贝贝,汪涛,徐丹,文富强
DOI: https://doi.org/10.3969/j.issn.1672-3511.2008.03.006
2008-01-01
Abstract:Objective To examine the influence of phosphodiesterase-4(PDE4) inhibitor YM976 on the pulmonary mucus secretion of chronic obstructive pulmonary diseases(COPD).Methods Rat pulmonary mucus hypersecretion was induced by acrolein.Rats treated with or without acrolein were orally administered with YM976(4.5 mg/kg) for 12 days.Macrophages were detected by cell count of bronchoalveolar lavage fluid(BALF).MUC5AC in the lung was detected by RT-PCR and immunohistochemistry.Results YM976(4.5 mg/kg) significantly attenuated pulmonary MUC5AC expression stimulated by acrolein,and reduced the activation of macrophages in BALF(P0.05).Conclusion YM976 inhibits pulmonary inflammatory response and pulmonary mucus hypersecretion induced by acrolein.
What problem does this paper attempt to address?